Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00031694Phase 2Completed
Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Principalinvestigator
NCT00064259Phase 1/2Terminated
A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer
Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vincent Chung

City of Hope Medical Center

Related
9 trials

Shared therapeutic areas:

Acinar Cell Adenocarcinoma of the PancreasAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal Junction+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score21%

Hedy Kindler

University of Chicago Comprehensive Cancer Center

Related
6 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic CancerRecurrent Pancreatic Cancer+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score19%

Lakshmi Rajdev

ECOG-ACRIN Cancer Research Group

Related
4 trials

Shared therapeutic areas:

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+7 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score16%

Betty Ferrell

City of Hope Medical Center

Related
5 trials

Shared therapeutic areas:

Recurrent Gastric CancerRecurrent Pancreatic CancerStage III Pancreatic Cancer+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score13%

Virginia Sun

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IV Pancreatic CancerRecurrent Pancreatic Cancer+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Manish Sharma

University of Chicago Comprehensive Cancer Center

Related
4 trials

Shared therapeutic areas:

Stage III Pancreatic CancerStage IIIA Gastric CancerStage IIIB Gastric Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Caio Rocha Lima, MD

Wake Forest University Health Sciences

Related
4 trials

Shared therapeutic areas:

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Stephen Michael Hahn

Abramson Cancer Center at Penn Medicine

Related
6 trials

Shared therapeutic areas:

Recurrent Gastric CancerRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Vincent Chung, MD

City of Hope Medical Center

Related
6 trials

Shared therapeutic areas:

Recurrent Gastric CancerRecurrent Pancreatic CancerStage III Pancreatic Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Wen Wee Ma

Roswell Park Cancer Institute

Related
5 trials

Shared therapeutic areas:

Stage IV Pancreatic CancerDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00031694Phase 2PrincipalInvestigator

Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
Completed
NCT00064259Phase 1/2PrincipalInvestigator

A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer

Adenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionDiffuse Adenocarcinoma of the Stomach+11 more
Terminated

All 2 trials loaded